Biocryst Pharmaceuticals (BCRX) Non-Current Deffered Revenue (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted Non-Current Deffered Revenue of $8.8 million for Q1 2026, up 16253.7% on a QoQ basis from $54000.0 in Q4 2018.
Biocryst Pharmaceuticals (BCRX) Non-Current Deffered Revenue (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals' Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $8.8 million for Q1 2026.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (changed N/A YoY) and the FY2018 annual result came in at $54000.0, down 65.16% from the prior year.
- Non-Current Deffered Revenue was $8.8 million for Q1 2026 at Biocryst Pharmaceuticals, up from $54000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $8.8 million in Q1 2026 and bottomed at $8.8 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Biocryst Pharmaceuticals | 2.27 Bn | 2.20 Bn | 151.04 Mn | 8.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.83 Mn |
| Dec 31, 2018 | 54,000.00 |
| Sep 30, 2018 | 81,000.00 |
| Jun 30, 2018 | 107,000.00 |
| Mar 31, 2018 | 131,000.00 |
| Dec 31, 2017 | 155,000.00 |
| Sep 30, 2017 | 178,000.00 |
| Jun 30, 2017 | 201,000.00 |
| Mar 31, 2017 | 223,000.00 |
| Dec 31, 2016 | 244,000.00 |
| Sep 30, 2016 | 265,000.00 |
| Jun 30, 2016 | 8.78 Mn |
| Mar 31, 2016 | 313,000.00 |
| Dec 31, 2015 | 329,000.00 |
| Sep 30, 2015 | 345,000.00 |
| Jun 30, 2015 | 361,000.00 |
| Mar 31, 2015 | 3.26 Mn |
| Dec 31, 2014 | 394,000.00 |
| Sep 30, 2014 | 3.85 Mn |
| Jun 30, 2014 | 4.14 Mn |